Akari Therapeutics, Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Akari Therapeutics,.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for AKTX.

Recommendation Trends

Rating	Jul '22	Aug '22	Sep '22	Oct '22	Nov '22
Strong Buy	1	1	1	1	1
Buy	1	1	1	1	0
Hold	1	1	1	1	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	3	3	3	3	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+2,438.07%	Dec 5, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+6,668.19%	Nov 1, 2022
Arlinda Lee Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Mar 29, 2018
Madhu Kumar B. Riley Securities	B. Riley Securities	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Feb 8, 2018
Tim Lugo William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Sep 22, 2017

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

4.28M

EPS This Year

-3.47

EPS Next Year

-3.67

from -3.47

Year	2019	2020	2021	2022	2023	2024	2025
Revenue	-	-	-	-	-	-	4.28M
Revenue Growth	-	-	-	-	-	-	-
EPS	-20.00	-20.00	-	-	-	-3.47	-3.67
EPS Growth	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	4.4M
Avg	n/a	4.3M
Low	n/a	4.1M

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	-3.57	-3.78
Avg	-3.47	-3.67
Low	-3.33	-3.53

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.